Authors | Published year | Type | Country | Study centre | Subgroups analysis included |
Atsukawa et al32 | 2017 | Full paper | Japan | Multicentre | With/without RBV reduction; 2a/2b; cirrhosis/non-cirrhosis;<65/≥65; HCC/non-HCC. |
Chen et al33 | 2015 | Abstract | China | Single centre | Cirrhosis; TE. |
Doi et al34 | 2017 | Full paper | Japan | Multicentre | None. |
Ide et al35 | 2016 | Abstract | Japan | Multicentre | None. |
Ikeda et al36 | 2016 | Full paper | Japan | Multicentre | With/without RBV reduction; cirrhosis/non-cirrhosis; TN/TE; ≥65; HCC/non-HCC. |
Kanda et al37 | 2017 | Full paper | Japan | Single centre | 2a; cirrhosis/non-cirrhosis; TN/TE; <65/>65; HCC/non-HCC. |
Karino et al38 | 2017 | Abstract | Japan | Single centre | Cirrhosis/non-cirrhosis. |
Kozuka et al39 | 2017 | Full paper | Japan | Single centre | Cirrhosis/non-cirrhosis; TN/TE; <65/>65; HCC/non-HCC; 2a/2b. |
Morio et al40 | 2016 | Full paper | Japan | Multicentre | With/without RBV reduction; 2a/2b; cirrhosis/non-cirrhosis; TN/TE. |
Murakawa et al41 | 2017 | Full paper | Japan | Multicentre | With/without RBV reduction; cirrhosis/non-cirrhosis; TN/TE; 2a/2b. |
Nishida et al42 | 2016 | Full paper | Japan | Single centre | With/without RBV reduction; cirrhosis/non-cirrhosis; TN/TE;<65/>65; HCC/non-HCC. |
Ogawa et al43 | 2016 | Full paper | Japan | Multicentre | With/without RBV reduction; 2a/2b; cirrhosis/non-cirrhosis; TN/TE; <65/>65; HCC/non-HCC. |
Watanabe et al44 | 2017 | Full paper | Japan | Multicentre | Cirrhosis/non-cirrhosis; TN/TE. |
HCC, hepatocellular carcinoma; RBV, ribavirin; TE, treatment-experienced; TN, treatment-naïve.